and KR3 are reflected in the reduced slope of the regression lines. The recently recommended parameters markedly reduced the magnitude of estimates from serum enzyme measurements. However, they did not improve the correlation between those estimates and myocardial CPK depletion.
1. Shell WE, Kjekshus 
MI with Normal Coronaries in Toxic Cardiomyopathy
To the Editor: The March 1976 editorial by Arnett and Roberts suggested that coronary embolism was the basis for "acute myocardial infarction with angiographically normal coronary arteries." Several points of clarification might be made in the interpretation of infarction related to toxic cardiomyopathy.' A thromboembolic process was deemed unlikely in that study on the basis of several observations. The patients without previous infarction did not have prior heart failure, cardiomegaly, evidence of arrhythmias or valvular disease which appear to be prerequisites for embolization from the left heart chambers.2' Thrombocytosis and drugs affecting platelets were also not present. These patients were considered to have a preclinical form of toxic heart muscle disease" 4 6and mural thrombi have not been described at this stage.
The authors have suggested early clot lysis as the explanation for the normal angiograms. Such an interpretation after catheter-induced infarction may not be valid since thromboembolism may not be the sole mechanism for this mode of infarction and the resolution rate may be dissimilar from the spontaneous entity. These considerations indicate some hazard in using catheter-induced infarction for this purpose.
Crucial to the thromboembolic postulate is the demonstration in such patients that emboli emanating from the left heart are distributed to the systemic circulation in an incidence approximating that of proven mural thrombi. As a clinical model for the distribution of emboli in the arterial circulation, patients with prosthetic valves and a relatively high incidence of embolization show a striking noncoronary preponderance; only one of 27 affected the coronaries in one series" and two of 41 in another,7 which approximates the incidence with mural thrombi.' None of the total of 12 patients in our series, representing 20% of CCU admissions for the given period, had evidence of embolization to any organ.
Since angiography was not feasible during acute infarction, the presence of thromboembolism was assessed indirectly by serial determinations of circulating platelet levels, which are known to be altered during systemic thromboembolic phenomena.", B, The absence of a change in platelet count during the first day suggested that accelerated platelet turnover as a reflection of arterial thromboembolism was unlikely in these patients.
Finally, in three patients with toxic cardiomyopathy who died from subsequent reinfarction, there was no source of emboli in the left heart and none were found in the coronary arteries. This pathologic evidence is in agreement with a prior report showing that postmortem examination done within four days of infarction in the majority, a period presumably too brief for spontaneous lysis, revealed no embolic phenomena."0 As a working hypothesis, we view the pathogenesis in this small subset as extravascular, analogous to the muscle necrosis associated with the periarterial lesions of constrictive pericarditis," perhaps conditioned by the abnormal metabolism of the cardiac cell in chronic ethanolism. '5 during 1961-1965. prised to see in such a review article that no mention was made of the following points: 1) that ST-T changes may be seen in all 12 leads of the electrocardiogram, not just II, III and aVF, V4, V, and V., 2) lax ligaments, 3) the frequent association of abdominal pain in patients with mitral valve prolapse, 4) the dyspnea experienced by these patients and its relationship to abnormal diffusion capacities, and 5) the frequent association of headaches. In a "syndrome" which pathologically demonstrates myxomatous degeneration, changes in other organ systems are more than tenable.
It would seem appropriate at this time that those centers which are specifically interested in this syndrome organize a cooperative study to define the syndrome in its entirety and to make the appropriate correlations of signs and symptoms in various organ systems. For years, many of the patients who have finally been diag-nosed as mitral valve prolapse have been carried with a diagnosis of neuroses. Modern technology has helped remove this label, at least from some of the patients in relationship to chest pain, but what about those patients who have had unexplained dyspnea, headaches, and abdominal pain. I would be very interested in the authors' comments in relationship to these particular facets of this "syndrome" and whether or not, in their large series, they have specifically questioned their patients in this regard. JOSEPH P. Liss, Jr., M.D.
University of Connecticut Farmington, Connecticut
The authors reply: To the Editor: I thank Dr. Joseph P. Liss, Jr., for his letter and hasten to reply. Let me respond to points one through five. We called attention in the text to the most typical electrocardiographic abnormality, namely, flattened or inverted T waves in leads II, III and aV,. Less commonly, these changes appear in lateral leads. Leads I and aVL are involved too sporadically to permit conclusions. Patients have been examined specifically for lax ligaments, but this abnormality has not been convincingly identified except in those with Marfan's syndrome. Frequent, significant abdominal pain (analogous to the chest pain) or headache (points 3 and 5) have not been found in our experience, but ill defined abdominal symptoms and headache may occur in the setting of psychophysiologic complaints. Specific attention was called to such complaints in the text. We also pointed out that "fatigue and dyspnea are frequent and often long proceed medical recognition of mitral prolapse." We further called attention to a decrease in exercise tolerance on formal stress testing. There has been no relationship, in our experience, between specific abnormalities of pulmonary function (including abnormal diffusion capacities), and dyspnea.
We agree with Dr. Liss that patients, especially young women with unexplained dyspnea, headache and apparent psychophysiologic complaints should be examined with mitral prolapse in mind. I confess however that identification of mitral prolapse in such patients merely reduces our ignorance by one step and exchanges one set of unknowns for another, since the cause of the neurotic behavior remains obscure.
I was gratified by interest of Dr. Liss in our paper and I thank him for his letter. JOSEPH K. PERLOFF, M.D. University of Pennsylvania Philadelphia, Pennsylvania
